BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20655307)

  • 1. Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells.
    Pan H; Bachelder RE
    Exp Cell Res; 2010 Oct; 316(17):2825-32. PubMed ID: 20655307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells.
    Pan H; Wanami LS; Dissanayake TR; Bachelder RE
    Breast Cancer Res Treat; 2009 Nov; 118(1):197-205. PubMed ID: 18787945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E.
    Li C; Sasaki Y; Takei K; Yamamoto H; Shouji M; Sugiyama Y; Kawakami T; Nakamura F; Yagi T; Ohshima T; Goshima Y
    J Neurosci; 2004 Jul; 24(27):6161-70. PubMed ID: 15240808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine semaphorin 3A signaling promotes glioblastoma dispersal.
    Bagci T; Wu JK; Pfannl R; Ilag LL; Jay DG
    Oncogene; 2009 Oct; 28(40):3537-50. PubMed ID: 19684614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.
    Bachelder RE; Lipscomb EA; Lin X; Wendt MA; Chadborn NH; Eickholt BJ; Mercurio AM
    Cancer Res; 2003 Sep; 63(17):5230-3. PubMed ID: 14500350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local translation of RhoA regulates growth cone collapse.
    Wu KY; Hengst U; Cox LJ; Macosko EZ; Jeromin A; Urquhart ER; Jaffrey SR
    Nature; 2005 Aug; 436(7053):1020-1024. PubMed ID: 16107849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin3A regulates neuronal polarization by suppressing axon formation and promoting dendrite growth.
    Shelly M; Cancedda L; Lim BK; Popescu AT; Cheng PL; Gao H; Poo MM
    Neuron; 2011 Aug; 71(3):433-46. PubMed ID: 21835341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.
    Decarlo L; Mestel C; Barcellos-Hoff MH; Schneider RJ
    Mol Cell Biol; 2015 Aug; 35(15):2597-609. PubMed ID: 25986608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
    Soni A; Akcakanat A; Singh G; Luyimbazi D; Zheng Y; Kim D; Gonzalez-Angulo A; Meric-Bernstam F
    Mol Cancer Ther; 2008 Jul; 7(7):1782-8. PubMed ID: 18644990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration.
    Nasarre C; Koncina E; Labourdette G; Cremel G; Roussel G; Aunis D; Bagnard D
    Cell Adh Migr; 2009; 3(4):383-9. PubMed ID: 19855168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.
    Zhou FF; Yan M; Guo GF; Wang F; Qiu HJ; Zheng FM; Zhang Y; Liu Q; Zhu XF; Xia LP
    Med Oncol; 2011 Dec; 28(4):1302-7. PubMed ID: 20652449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer.
    Yamada D; Takahashi K; Kawahara K; Maeda T
    Biochem Biophys Res Commun; 2016 Nov; 480(3):375-379. PubMed ID: 27769863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
    Villalonga P; Fernández de Mattos S; Ridley AJ
    J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupled local translation and degradation regulate growth cone collapse.
    Deglincerti A; Liu Y; Colak D; Hengst U; Xu G; Jaffrey SR
    Nat Commun; 2015 Apr; 6():6888. PubMed ID: 25901863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming.
    Geter PA; Ernlund AW; Bakogianni S; Alard A; Arju R; Giashuddin S; Gadi A; Bromberg J; Schneider RJ
    Genes Dev; 2017 Nov; 31(22):2235-2249. PubMed ID: 29269484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.